ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
119.780,56
0,13%
S&P 500
5.918,25
0,00%
US Dollar vs BRL
6,0354
-1,18%
Bitcoin
91.920,27
-3,30%
Brent Oil
76,985
1,31%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Sana Biotechnology Inc (SANA)

  7. Sana Biotechnology Inc (SANA) Notícias

SANA

Sana Biotechnology (SANA)

Sana Biotechnology Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:SANA
DataHoraFonteTítuloCódigoCompanhia
08/01/202518:05GlobeNewswire Inc.Sana Biotechnology to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SANASana Biotechnology Inc
07/01/202518:05GlobeNewswire Inc.Sana Biotechnology Announces Positive Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without ImmunosuppressionNASDAQ:SANASana Biotechnology Inc
16/12/202418:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:SANASana Biotechnology Inc
02/12/202411:00GlobeNewswire Inc.Sana Biotechnology Announces Fast Track Designation for SC291 in Relapsed/Refractory Systemic Lupus ErythematosusNASDAQ:SANASana Biotechnology Inc
25/11/202418:05GlobeNewswire Inc.Sana Biotechnology to Present at December 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
08/11/202411:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SANASana Biotechnology Inc
08/11/202411:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SANASana Biotechnology Inc
08/11/202411:00GlobeNewswire Inc.Sana Biotechnology Reports Third Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
04/11/202418:30GlobeNewswire Inc.Sana Biotechnology Announces Increased Focus on Type 1 Diabetes and B-cell Mediated Autoimmune Diseases with the Potential to Deliver Clinical Proof of Concept Data Across Multiple Studies in 2024 and 2025NASDAQ:SANASana Biotechnology Inc
23/10/202409:00PR Newswire (US)Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering IntelligenceNASDAQ:SANASana Biotechnology Inc
03/10/202409:00PR Newswire (US)Invaio Sciences Appoints André Andonian as Chairman of the Board of DirectorsNASDAQ:SANASana Biotechnology Inc
30/09/202417:05GlobeNewswire Inc.Sana Biotechnology to Present at the Goldman Sachs Cell Therapy Day ConferenceNASDAQ:SANASana Biotechnology Inc
29/08/202417:05GlobeNewswire Inc.Sana Biotechnology to Present at September 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
26/08/202417:05GlobeNewswire Inc.Sana Biotechnology Appoints Accomplished Drug Developer Dhaval Patel, M.D., Ph.D., as Executive Vice President and Chief Scientific OfficerNASDAQ:SANASana Biotechnology Inc
08/08/202417:05GlobeNewswire Inc.Sana Biotechnology Reports Second Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
06/08/202407:30PR Newswire (US)Flagship Pioneering Announces Appointment of Raj Panjabi as Senior PartnerNASDAQ:SANASana Biotechnology Inc
15/07/202417:12Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:SANASana Biotechnology Inc
07/06/202417:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
21/05/202410:00GlobeNewswire Inc.Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other GliaNASDAQ:SANASana Biotechnology Inc
08/05/202417:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SANASana Biotechnology Inc
08/05/202417:05GlobeNewswire Inc.Sana Biotechnology Reports First Quarter 2024 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
06/05/202417:05GlobeNewswire Inc.Sana Biotechnology to Present at May and June 2024 Investor ConferencesNASDAQ:SANASana Biotechnology Inc
29/02/202418:05GlobeNewswire Inc.Sana Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:SANASana Biotechnology Inc
28/02/202418:05GlobeNewswire Inc.Sana Biotechnology to Present at the Cowen 44th Annual Health Care ConferenceNASDAQ:SANASana Biotechnology Inc
14/02/202418:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SANASana Biotechnology Inc
13/02/202418:05GlobeNewswire Inc.Sana Biotechnology Announces Publication of Preclinical Diabetes Data in Cell Stem Cell Demonstrating Insulin Independence Following Transplantation of Hypoimmune Allogeneic Primary Islet Cells Without Immunosuppression in a Diabetic NHPNASDAQ:SANASana Biotechnology Inc
12/02/202418:05GlobeNewswire Inc.Sana Biotechnology Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:SANASana Biotechnology Inc
08/02/202418:49Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SANASana Biotechnology Inc
08/02/202403:22GlobeNewswire Inc.Sana Biotechnology Announces Pricing of Upsized Public OfferingNASDAQ:SANASana Biotechnology Inc
07/02/202423:59Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:SANASana Biotechnology Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:SANA

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PMAM3
PARANAPANEMA ON
BOV
AZEV4
AZEVEDO PN
BOV
FICT3
Fictor Alimentos ON
BOV
RAIZ4
Raizen S.A PN
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
PRIO3
PETRORIO ON
BOV
RCSL4
RECRUSUL PN
BOV
TELB4
TELEBRAS PN
BOV
ELET3
ELETROBRAS ON
BOV
GOLL4
GOL PN
BOV
CSAN3
COSAN ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
COCE5
COELCE PNA
BOV
TECN3
TECHNOS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados